Overview

The Influence of Timing of Cabergoline Initiation on Prevention of OHSS

Status:
Unknown status
Trial end date:
2019-04-01
Target enrollment:
0
Participant gender:
Female
Summary
Study the effect of early cabergoline administration in prevention of occurrence or decreasing the severity of OHSS in patients undergoing intra cytoplasmic sperm injection.And its effect on oocyte maturation,fertilization and pregnancy rate..
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Mona M Shaban
Treatments:
Cabergoline
Criteria
Inclusion Criteria:

- Female less than 35 years under going Intra cytoplasmic sperm injection cycle for
infertility (tubal factor or un explained infertility).

- 18 or more oocyte 11 mm in diameter and/or E2 is more than 4000 pg/ml at any day of
the stimulation cycle before or at HCG trigger

Exclusion Criteria:

- patient with one ovary

- patients already receiving cabergoline treatment

- Severe Male factor infertility.

- Thyroid dysfunction.